Bupropion extended release tablets recalled after failing tablet specifications
Graviti Pharmaceuticals is recalling 46,512 bottles of Bupropion Hydrochloride Extended-Release Tablets USP (XL) 300 mg from one batch for failed tablet specifications.
- Product
- BUPROPION HYDROCHLORIDE — BUPROPION HYDROCHLORIDE (BUPROPION HYDROCHLORIDE)
- Category
- Drug
- Distribution
- Distributed nationwide